QuickBird Medical
  • Case Studies
    • Case Studies
    • Customers
  • Services
    • Development: DiGA
    • Development: Medical Software
    • Development: Health Apps
    • Development: Decision Support Systems
    • Development: Wearables for Medical Devices
    • Legal Manufacturer for Medical Devices
    • BSI TR-03161 for DiGA
    • Support for your Software Team
    • Further Services
  • Insights
  • About us
    • Team
    • Jobs
  • Contact
  • German
Select Page
Requirements of the ISO 13485 – A comprehensive guide

Requirements of the ISO 13485 – A comprehensive guide

by Alexander Fenkiw | Nov 10, 2022 | medical-software-whitepaper, Unkategorisiert

Anyone involved in the development of software medical devices is certainly no stranger to the term “Quality management system” (QMS). You may also have heard of ISO 13485 in this context. ISO 13485 is a standard that defines the requirements for a quality...
Guide to §374a SGB V – Interoperability for DiGA, aids & implants

Guide to §374a SGB V – Interoperability for DiGA, aids & implants

by Alexander Fenkiw | May 3, 2022 | Unkategorisiert

Attention manufacturers of electronic aids, implants and DiGA! From mid-2024, a new legal requirement will apply to improve interoperability between medical devices and digital health applications (DiGA) approved by the BfArM: §374a SGB V Specifically, this involves...
Approval & certification of software medical devices (MDR)

Approval & certification of software medical devices (MDR)

by Alexander Fenkiw | Mar 31, 2022 | medical-software-whitepaper, medical-software-whitepaper

How does medical device approval for software work? How long does this process take? And what are the costs involved in certification? The path to medical device approval is also complex for software products. It is therefore advisable to deal with the...
MDR Guide: Clinical evaluation of software medical devices

MDR Guide: Clinical evaluation of software medical devices

by Alexander Fenkiw | Jan 24, 2022 | Unkategorisiert

“Clinical evaluation? No problem!” “A doctor was recently interviewed in the Süddeutsche Zeitung! She clearly stated that mindfulness apps help with depression. We can refer to that, can’t we?” Unfortunately, it’s not that simple....
DiGA: Guidelines for demonstrating positive supply effects

DiGA: Guidelines for demonstrating positive supply effects

by Alexander Fenkiw | Jun 18, 2021 | Unkategorisiert

 What is the point of a DiGA if it does not improve patients’ lives? There is none! This is why DiGAs are only justified when their positive supply effect has been proven. Only then do you have a chance of being permanently included in the BfArM register....
Next Entries »

Insider-Empfehlungen für DiGA-Hersteller in 2025
Downloaden Sie jetzt unser Whitepaper

Insider-Empfehlungen für Software-Medizinprodukt-Hersteller in 2025
Downloaden Sie jetzt unser Whitepaper


Sie planen eine Medical Software oder DiGA?

Sprechen Sie mit unserem Geschäftsführer Malte Bucksch

+49 (0) 89 54998380
kontakt@quickbirdmedical.com
Kontakt

+49 (0) 89 54998380
kontakt@quickbirdmedical.com

 

Whitepaper

13 wichtige Empfehlungen für angehende DiGA-Hersteller 2025

13 wichtige Empfehlungen für angehende Medizinprodukt-Hersteller 2025

Current

DiGA und Medical Software News

Digital Health Events 2025

Presse – QuickBird in den Medien

© 2025 Impressum | Datenschutz